MNKD to Participate in 2021 SVB Leerink Global Healthcare Co

[kite]

www.globenewswire.com/news-release/2021/02/18/2178550/0/en/MannKind-Corporation-to-Participate-in-2021-SVB-Leerink-Global-Healthcare-Conference.html


WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the 2021 SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 1:00 pm (ET). Interested parties can access a link to the webcast from the Events & Presentations section of the Company's website at www.mannkindcorp.com. The webcast replay will remain available for 14 days following the live presentation.

About MannKind Corporation

MannKind Corporation (NASDAQ: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company’s first FDA-approved product and the only inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com.

Company Contact:
818-661-5000
[e-mail]

[peppy]

Feb 18, 2021 17:01:32 GMT -5 kite said:

www.globenewswire.com/news-release/2021/02/18/2178550/0/en/MannKind-Corporation-to-Participate-in-2021-SVB-Leerink-Global-Healthcare-Conference.html


WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the 2021 SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 1:00 pm (ET). Interested parties can access a link to the webcast from the Events & Presentations section of the Company's website at www.mannkindcorp.com. The webcast replay will remain available for 14 days following the live presentation.

About MannKind Corporation

MannKind Corporation (NASDAQ: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company’s first FDA-approved product and the only inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com.

Company Contact:
818-661-5000
ir@

investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2020-fourth-quarter-and-full-year
9am EST

MannKind Corporation to Hold 2020 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2021

Same day.

[sportsrancho]

🤦🏼‍♀️

[lennymnkd]

Sens announced it 7 days ago ! Maybe Mnkd had some planning to do.

[mytakeonit]

So CC is at 9am ET and the fireside chat is at 1pm ET ... ET call home. Hawaii has 5 hours time difference ... so I'll wake up later and maybe catch the fireside chat.

But, that's mytakeonit

[longliner]

Next week should be a monster news cycle for Mannkind.

[mytakeonit]

So I should buy another million shares

But, that's mytakeonit

[letitride]

Feb 18, 2021 17:50:51 GMT -5 mytakeonit said:

So I should buy another million shares

But, that's mytakeonit

       Someday soon I may be able to count that high to.
             Lets Go!

[porkini]

Feb 18, 2021 17:50:51 GMT -5 mytakeonit said:

So I should buy another million shares

But, that's mytakeonit

Why so unhappy?

[mytakeonit]

I thought 400k shares was enough ... If I have to buy another million shares ... if I don't buy really soon ... it'll cost me $6M or MORE !!!

But, that's mytakeonit

[veritasfiliatemporis]

"MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases" 🤔 I didn't notice it... 🤔 and Afrezza..

[Clement]

Diabetes is the most common endocrine disorder.

[celo]

Fireside chat in an hour and half. Stock price moving up. All those positives to talk about in the annual report!

[celo]

Mike said their partnership with United will open so many doors. I really believe that also. Especially, as it seems, in the 50 patients that were administered Tyvaso DPI there is improvement in walking and moving. As Tyvaso DPI patients see more improvement this will only accelerate. We are at the tip of the iceberg.

[boca1girl]

I thought his talk was much more bullish about future opportunities than the earnings call. SP has held up pretty well today.